Journals & Clinical Evidence

Treatment of obstructive sleep apnea in high risk pregnancy: a multicenter randomized controlled trial

Curated research to understand technology benefits, comparisons, and limitations, prioritizing studies that identify devices or brands in our portfolio.

Brochures & Media Journals & Clinical Evidence Solutions by Specialty

All journals Urology Obstetrics & Gynecology Orthopedics & Pain Surgery & Proctology Respiratory & Sleep Medicine Plastic & Reconstructive Surgery Dermatology & Aesthetics

Search procedures, conditions, devices, or authors

1 publication

Brands in our portfolio2023 · Tantrakul V et al.

CPAP in high-risk pregnancy with OSA

Treatment of obstructive sleep apnea in high risk pregnancy: a multicenter randomized controlled trial
Respiratory research

Open-label randomised trial · Three hospitals · 310 participants in the primary analysis

Findings: Diastolic blood pressure decreased by an average of 2.2 mmHg. Preeclampsia occurred in 13.1% of the CPAP group vs 22.3% with usual care.

Points to consider: 96.5% were recruited in the first trimester; this was not a trial of starting CPAP specifically in trimester III. Mean adherence was 2.5 hours/night. Findings apply to the high-risk OSA population studied.

Device & relevance: Philips Respironics REMstar Auto M / DreamStation named in the methods; the currently offered model needs to be matched.

Read publication ↗Full text at publisher / repository ↗Overview link

DOI: 10.1186/s12931-023-02445-y

Treatment of obstructive sleep apnea in high risk pregnancy: a multicenter randomized controlled trial

CPAP in high-risk pregnancy with OSA

Reading evidence in context.